Angelica Nogueira-Rodrigues
Overview
Explore the profile of Angelica Nogueira-Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quesada S, Penault-Llorca F, Matias-Guiu X, Banerjee S, Barberis M, Coleman R, et al.
Eur J Cancer
. 2024 Dec;
215:115169.
PMID: 39693891
Background: Poly (ADP ribose) polymerase inhibitors (PARPis) are a treatment option for patients with advanced high-grade serous or endometrioid ovarian carcinoma (OC). Recent guidelines have clarified how homologous recombination deficiency...
2.
Campuzano T, Borba M, Batista P, Nadalin M, Marcelino C, Pungartnik P, et al.
PLoS One
. 2024 Oct;
19(10):e0312757.
PMID: 39475907
The aim of the study is to evaluate the treatment patterns, time to start treatment, and healthcare resources utilization (HCRU) of cervical cancer (CC) patients within the Brazilian public health...
3.
Filho A, Reis Romualdo G, Pinhati M, Neves G, Oliveira J, Moretti-Marques R, et al.
Int J Gynecol Cancer
. 2024 Oct;
PMID: 39366720
Objective: To evaluate the correlation between socioeconomic and healthcare factors and cervical cancer mortality rates, as well as the accessibility to prevention and treatment across Brazilian states and macroregions. The...
4.
Ribeiro-Santos P, Martins Vieira C, Viana Veloso G, Giannecchini G, Arenhardt M, Gomes L, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062983
Endometrial cancer (EC) is a heterogeneous disease with a rising incidence worldwide. The understanding of its molecular pathways has evolved substantially since The Cancer Genome Atlas (TCGA) stratified endometrial cancer...
5.
Olawaiye A, Kim J, Bagameri A, Bishop E, Chudecka-Glaz A, Devaux A, et al.
J Gynecol Oncol
. 2024 Jul;
35(4):e111.
PMID: 39032926
Background: Ovarian cancer has the highest mortality among gynecologic cancers, primarily because it typically is diagnosed at a late stage and because of the development of chemoresistance in recurrent disease....
6.
Nogueira-Rodrigues A, Cetina Perez L, Maza M
Front Oncol
. 2024 May;
13:1226915.
PMID: 38778839
No abstract available.
7.
Ranniger R, Lamaita R, DAbreu B, Tolentino M, Batista Candido E, Andrade W, et al.
Rev Bras Ginecol Obstet
. 2024 May;
46.
PMID: 38765513
Objective: Fertility preservation is a priority in oncology for female cancer patients. However, there is a lack of communication between infertility specialists and oncologists. This study aimed to evaluate infertility...
8.
Blanco A, Nogueira-Rodrigues A, Carvalho F, Giornelli G, Mirza M
Int J Gynecol Cancer
. 2024 May;
34(8):1263-1272.
PMID: 38697755
Molecular characterization of endometrial cancer is allowing for increased understanding of the natural history of tumors and paving a more solid pathway for novel therapies. It is becoming increasingly apparent...
9.
Viana Veloso G, Amaral F, Nogueira-Rodrigues A
BMC Cancer
. 2024 Apr;
24(1):539.
PMID: 38679710
Background: There is no updated national data regarding the real impact of the COVID-19 pandemic on delaying diagnosis and treatment among patients with lung, and head, and neck cancers in...
10.
Nogueira-Rodrigues A, Giannecchini G, Secord A
Gynecol Oncol
. 2024 Mar;
185:180-185.
PMID: 38442493
Ovarian cancer (OC) is a global health problem, and the mortality-to-incidence ratio is expected to increase, especially in low- and middle-income countries. These regions face disparities in access to OC...